FibroGen, Inc.

( )
FGEN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 8.11%169.500.0%$1483.94m
NVAXNovavax, Inc. 2.25%212.8380.0%$625.43m
SNSSSunesis Pharmaceuticals, Inc. 3.48%8.040.7%$562.03m
AMGNAmgen, Inc. -0.14%258.781.3%$554.57m
ILMNIllumina, Inc. 1.24%403.333.5%$501.88m
REGNRegeneron Pharmaceuticals, Inc. 0.41%506.482.7%$449.94m
GILDGilead Sciences, Inc. 0.62%66.791.0%$433.53m
BNTXBioNTech SE 3.60%161.800.0%$385.45m
VRTXVertex Pharmaceuticals, Inc. -0.18%219.761.9%$373.88m
ALXNAlexion Pharmaceuticals, Inc. 1.14%168.442.0%$372.56m
BIIBBiogen, Inc. -1.23%269.851.7%$244.93m
CRSPCRISPR Therapeutics AG 2.68%124.930.6%$186.56m
NBIXNeurocrine Biosciences, Inc. 0.91%97.034.9%$178.13m
EXASEXACT Sciences Corp. 2.49%128.7518.4%$165.21m
OCGNOcugen, Inc. 17.75%6.500.0%$162.52m

Company Profile

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.